Elevance Health Inc
NYSE:ELV

Watchlist Manager
Elevance Health Inc Logo
Elevance Health Inc
NYSE:ELV
Watchlist
Price: 410.89 USD -0.49% Market Closed
Market Cap: 95.3B USD
Have any thoughts about
Elevance Health Inc?
Write Note

Intrinsic Value

The intrinsic value of one ELV stock under the Base Case scenario is 736.94 USD. Compared to the current market price of 410.89 USD, Elevance Health Inc is Undervalued by 44%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ELV Intrinsic Value
736.94 USD
Undervaluation 44%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Elevance Health Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for ELV cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about ELV?
Bearish
Neutral
Bullish

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Elevance Health Inc

Provide an overview of the primary business activities
of Elevance Health Inc.

What unique competitive advantages
does Elevance Health Inc hold over its rivals?

What risks and challenges
does Elevance Health Inc face in the near future?

Has there been any significant insider trading activity
in Elevance Health Inc recently?

Summarize the latest earnings call
of Elevance Health Inc.

What significant events have occurred
in Elevance Health Inc over the past months?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Elevance Health Inc.

Provide P/S
for Elevance Health Inc.

Provide P/E
for Elevance Health Inc.

Provide P/B
for Elevance Health Inc.

Show me price targets
for Elevance Health Inc made by professional analysts.

What are the Revenue projections
for Elevance Health Inc?

How accurate were the past Revenue estimates
for Elevance Health Inc?

What are the Net Income projections
for Elevance Health Inc?

How accurate were the past Net Income estimates
for Elevance Health Inc?

What are the EPS projections
for Elevance Health Inc?

How accurate were the past EPS estimates
for Elevance Health Inc?

What are the EBIT projections
for Elevance Health Inc?

How accurate were the past EBIT estimates
for Elevance Health Inc?

Compare the revenue forecasts
for Elevance Health Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Elevance Health Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Elevance Health Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Elevance Health Inc compared to its peers.

Compare the P/E ratios
of Elevance Health Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Elevance Health Inc with its peers.

Analyze the financial leverage
of Elevance Health Inc compared to its main competitors.

Show all profitability ratios
for Elevance Health Inc.

Provide ROE
for Elevance Health Inc.

Provide ROA
for Elevance Health Inc.

Provide Net Margin
for Elevance Health Inc.

Show all solvency ratios
for Elevance Health Inc.

What is the historical Revenue growth
over the last 5 years for Elevance Health Inc?

What is the historical Net Income growth
over the last 5 years for Elevance Health Inc?

What is the current Free Cash Flow
of Elevance Health Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Elevance Health Inc.

Business Breakdown

Elevance Health Inc., formerly known as Anthem Inc., is a leading health benefits company that has made significant strides in transforming healthcare delivery in the United States. With a mission to improve lives and ensure access to healthcare, Elevance operates a diversified portfolio of health plans that cover millions of members across various states. The company has positioned itself as a key player in the healthcare ecosystem by leveraging technology and innovative solutions to enhance patient care, streamline operations, and optimize costs. As rising healthcare demands present both challenges and opportunities, Elevance is committed to creating value for its stakeholders through stra...

Read More
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Elevance Health Inc

Cash & Short-Term Investments 7.9B
Insurance Receivable 18.4B
PP&E 4.5B
Long-Term Investments 40.4B
Other Assets 45.4B
Insurance Policy Liabilities 15.3B
Short Term Debt 360m
Long Term Debt 24.7B
Other Liabilities 32.4B
Earnings Calls

Elevance Health reported Q3 adjusted EPS of $8.37, below expectations due to elevated Medicaid costs. The company lowered its 2024 EPS guidance to approximately $33, as Medicaid rate increases lag behind cost trends, now 3x to 5x historical averages. They are confident that collaboration with state partners will eventually align rates with member acuity. For 2025, they expect strong growth across commercial and Medicare businesses, with anticipated revenue growth in the high single-digit range. Despite near-term Medicaid headwinds, Elevance remains optimistic about sustainable future growth, driven by strategic investments and operational efficiencies.

What is Earnings Call?

Wall St
Price Targets

ELV Price Targets Summary
Elevance Health Inc

Wall Street analysts forecast ELV stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ELV is 563.11 USD with a low forecast of 469.65 USD and a high forecast of 698.25 USD.

Lowest
Price Target
469.65 USD
14% Upside
Average
Price Target
563.11 USD
37% Upside
Highest
Price Target
698.25 USD
70% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for ELV?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Previous Payment
-
Today
Next Payment
-
Today
Nov 14, 2024
Previous Payment
-
Next Payment
-
Ex-Dividend Date
-
Shareholder Yield

Current shareholder yield for ELV is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest

Ownership

ELV Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

ELV News

Other Videos

Profile

Elevance Health Inc Logo
Elevance Health Inc

Country

United States of America

Industry

Health Care

Market Cap

95.3B USD

Dividend Yield

1.55%

Description

Anthem, Inc. provides life, hospital and medical insurance plans. The company is headquartered in Indianapolis, Indiana and currently employs 98,200 full-time employees. The company went IPO on 2001-10-30. The company is focused on whole health. The company supports health at every life stage, offering health plans and clinical, behavioral, pharmacy and complex-care solutions that promote whole health. The company identifies the resources needed to support residents, including the people it serves, and ensure those resources meet local needs. The company focuses on advancing health equity, such as ensuring people with disabilities and rural residents can find accessible care. Additionally, it also focuses on prioritizing three areas, such as maternal health, behavioral health, and access to evidence-based medical therapy. The company also focuses on providing digitally enabled healthcare. The company provides a consumer-centered health system. Carelon is its healthcare services brand and Wellpoint is its health plan brand. Its other brands include Anthem Blue Cross and Blue Shield. Through these brands, it focuses on delivering solutions beyond traditional health insurance.

Contact

INDIANA
Indianapolis
220 Virginia Avenue
+13174886000
www.antheminc.com

IPO

2001-10-30

Employees

98 200

Officers

President, CEO & Director
Ms. Gail Koziara Boudreaux
Executive VP & CFO
Mr. Mark Bradley Kaye
Executive VP and Chief Legal & Administrative Officer
Mr. Blair Williams Todt
Executive VP and President of Carelon & CarelonRx
Mr. Peter David Haytaian Esq.
Executive VP & President of Government Health Benefits
Ms. Felicia Farr Norwood
SVP, Treasurer & Chief Investment Officer
Mr. Scott Wayne Anglin
Show More
Senior VP, Controller & Chief Accounting Officer
Mr. Ronald William Penczek
Vice President of Investor Relations
Mr. Stephen Vartan Tanal C.F.A.
Senior Vice President of Public Affairs
Ms. Julie Goon
Chief Strategy Officer & Interim Chief Marketing Officer
Mr. Kyle Weber
Show Less

See Also

Discover More
What is the Intrinsic Value of one ELV stock?

The intrinsic value of one ELV stock under the Base Case scenario is 736.94 USD.

Is ELV stock undervalued or overvalued?

Compared to the current market price of 410.89 USD, Elevance Health Inc is Undervalued by 44%.

Back to Top